72 completed, 35 unknown, 25 terminated, 17 recruiting. 53 Phase 3, 42 Phase 4, 34 Phase 2, 18 Not applicable, 5 Phase 1.
Follow Azathioprine: new trials by email Literature Review of Azathioprine trials Research Report on Azathioprine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rituximab With Corticosteroids Versus Corticosteroids Plus Azathioprine for Moderate-to-Severe Pemphigus Vulgaris Rituxan (rituximab), Azathioprine (AZA)' plus corticosteroids - Pemphigus Vulgaris, Rituximab (RTx) | Early Phase 1 | Not yet recruiting | Khyber Teaching Hospital | 92 | 2026-12-02 | 2026-08-18 |
| Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's Disease Azathioprine + infliximab, Intestinal resection - Crohn Disease | Not applicable | Not yet recruiting | Nantes University Hospital | 150 | 2026-10-01 | 2026-06-23 |
| Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease Cyclophosphamide 50mg, Abatacept, Alemtuzumab - Sickle Cell Disease | Phase 2 | Recruiting | St. Jude Children's Research Hospital | 45 | 2026-09-01 | 2026-07-23 |
| Utilization of a Microdevice for Psoriasis and Atopic Dermatitis In situ cutaneous microdevice, Triamcinolone, 5-Fluorouracil - Psoriasis, Atopic Dermatitis | Phase 4 | Not yet recruiting | University of California, San Francisco | 10 | 2026-08-01 | 2026-06-03 |
| Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed, Moderate-to-severe Crohn's Disease Mirikizumab, Azathioprine (AZA) - Chrohn's Disease | Phase 4 | Not yet recruiting | University Hospital Schleswig-Holstein | 320 | 2026-08-01 | 2026-06-22 |
| CD38 mAb Induction + Azathioprine Maintenance for Chronic Active AMR in Kidney Transplant Recipients CD38, Azathioprine (AZA), Standard Triple Immunosuppression Maintenance - Kidney Transplantation, Antibody-mediated Rejection | Not applicable | Not yet recruiting | wujianyong | 20 | 2026-07-15 | 2026-07-21 |
| PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure methoxsalen, Extracorporeal photopheresis (ECP), Vedolizumab - Colitis, Hepatitis | Phase 2 | Not yet recruiting | Therakos LLC | 112 | 2026-07-01 | 2026-06-02 |
| Immunosuppressant Discontinuation in Elderly Patients With Ulcerative Colitis And Long-term Remission Discontinuation of thiopurines. - Ulcerative Colitis (UC) | Phase 4 | Not yet recruiting | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | 304 | 2026-05-01 | 2026-04-15 |
| Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis Ozanimod, Azathioprine - Ulcerative Colitis (UC) | Recruiting | Bristol-Myers Squibb | 150 | 2026-01-29 | 2026-05-18 | |
| Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty Methotrexate, Sulfasalazine, Hydroxychloroquine - Rheumatic Disease | Phase 2 | Recruiting | NYU Langone Health | 80 | 2025-12-12 | 2026-07-09 |
| Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe Ulcerative Colitis Mirikizumab, Azathioprine (AZA) - Ulcerative Colitis (UC) | Phase 4 | Recruiting | University Hospital Schleswig-Holstein | 300 | 2025-12-05 | 2025-12-16 |
| Pragmatic, Open-Label Study to Pilot Evaluation for Clinical Trials in Relapsing Polychondritis Methotrexate (MTX), Azathioprine (AZA), Adalimumab - Relapsing Polychondritis | Phase 2 | Recruiting | University of Pennsylvania | 20 | 2025-11-11 | 2026-09-02 |
| BDB-001 Phase III Trial in ANCA-Associated Vasculitis BDB-001 injection, Cyclophosphamide, Rituximab - ANCA Associated Vasculitis (AAV) | Phase 3 | Recruiting | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 300 | 2025-11-10 | 2026-08-13 |
| Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo Azathioprine, Tofacitinib - Vitiligo | Phase 1 | Active not recruiting | Lahore General Hospital | 20 | 2025-03-01 | 2025-06-29 |
| Beneficial Effect of Silymarin in Ulcerative Colitis Silymarin, Mesalamine, Azathioprine - Ulcerative Colitis | Phase 2 | Recruiting | Tanta University | 44 | 2025-02-01 | 2025-03-05 |
| Induction of Remission in Autoimmune Hepatitis With Azathioprine vs. MMF Mycophenolate Mofetil + Prednisolone Participants will receive mycophenolate mofetil in combination., Azathioprine + Prednisolone - Autoimmune Hepatitis | Phase 2 / Phase 3 | Not yet recruiting | Institute of Liver and Biliary Sciences, India | 108 | 2024-11-01 | 2024-11-07 |
| Comparison of Efficacy of Methotrexate and Azathioprine in Patients With Chronic Actinic Dermatitis: A Randomized Controlled Trial Azathioprine, Methotrexate - Chronic Actinic Dermatitis | Early Phase 1 | Completed | Pak Emirates Military Hospital | 50 | 2024-07-14 | 2026-05-11 |
| Azathioprine in MOGAD Azathioprine, Placebo - Central Nervous System Inflammation, MOG-IgG Associated Disease | Phase 3 | Recruiting | Hospices Civils de Lyon | 126 | 2023-12-12 | 2025-02-04 |
| Early Use of Long-acting Tacrolimus in Lung Transplant Recipients Tacrolimus Extended Release Oral Tablet [Envarsus], Tacrolimus, Mycophenolate Mofetil Hydrochloride - Lung Transplant; Complications | Early Phase 1 | Recruiting | Vanderbilt University Medical Center | 48 | 2023-12-01 | 2026-05-15 |
| Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis Baricitinib 4 MG, Azathioprine 1.5-2.5 mg/kg - Atopic Dermatitis | Not applicable | Completed | Mazandaran University of Medical Sciences | 40 | 2023-08-15 | 2025-12-15 |
Showing 20 of 167. Sign in to see all of them.
Crohn Disease (34) · Colitis, Ulcerative (15) · Lupus Nephritis (13) · Vasculitis (13) · Lupus Erythematosus, Systemic (11) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (10) · Granulomatosis with Polyangiitis (10) · Inflammatory Bowel Diseases (10) · Microscopic Polyangiitis (10) · Neuromyelitis Optica (6) · Arthritis, Rheumatoid (5) · Churg-Strauss Syndrome (5) · Hepatitis, Autoimmune (5) · Myasthenia Gravis (4) · Autoimmune Diseases (3)
Assistance Publique - Hôpitaux de Paris (7) · Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives (4) · Hoffmann-La Roche (4) · Hospices Civils de Lyon (4) · National Institute of Allergy and Infectious Diseases (NIAID) (4) · Sixth Affiliated Hospital, Sun Yat-sen University (4) · Chinese SLE Treatment And Research Group (3) · Erasmus Medical Center (3) · Merck Sharp & Dohme LLC (3) · A. Manzoni Hospital (2) · Genentech, Inc. (2) · GlaxoSmithKline (2) · Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (2) · JHSPH Center for Clinical Trials (2) · Jinling Hospital, China (2)
United States (36) · China (23) · France (22) · Germany (14) · United Kingdom (13) · Canada (12) · Italy (11) · Belgium (10) · Netherlands (10) · Spain (8) · Australia (7) · Czechia (7) · Switzerland (7) · Japan (6) · Sweden (6)
Betty Diamond, MD (2) · Loic Guillevin, MD, PhD (2) · Aharon Lerner, MD (1) · Ahmed H Salama (1) · Ahsan Tameez-ud-din (1) · Akshay Sharma, MBBS (1) · Akshay Sharma, MD (1) · Alberto Sanchez-Fueyo (1) · Aldo Iacono (1) · Alexander Jetter, MD (1)
PMID 40013523, PMID 24254965, PMID 25153486, PMID 11824975, PMID 11919310, PMID 12270445, PMID 12359731, PMID 15691277, PMID 15803929, PMID 15919463, PMID 16407509, PMID 16771810, PMID 17452226, PMID 18087004, PMID 18240234, PMID 18295023, PMID 18725917, PMID 19005182, PMID 19109574, PMID 19192962, PMID 19497063, PMID 19773418, PMID 19790150, PMID 19933596, PMID 20039429, PMID 20148887, PMID 20393175, PMID 20459775, PMID 20551460, PMID 20647199, PMID 20671616, PMID 20833822, PMID 21060104, PMID 21080348, PMID 21177013, PMID 21325604, PMID 21401729, PMID 21503695, PMID 21652026, PMID 21688345, PMID 21840602, PMID 21861971, PMID 22087680, PMID 22247489, PMID 22409563, PMID 22859346, PMID 22922564, PMID 22975753, PMID 23163490, PMID 2334081
2014 (3), 2005 (2), 2016 (2), 2008 (1), 2009 (1), 2017 (1), 2025 (1), P01DK058335 (1), P50HL056402 (1), R01HL059490 (1), U01DK060083 (1), U10EY014660 (1), U54AR057319 (1)